Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biol Trace Elem Res ; 196(2): 494-501, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31656014

RESUMEN

The purpose of this research is to investigate the absorption, distribution, excretion, and pharmacokinetics of selenite in rats after intragastric administration, and thus illustrate the efficiency of selenium (Se) supplementation. After a single gavage of sodium selenite, a concentration of Se in plasma and tissues was determined by inductively coupled plasma mass spectrometry (ICP-MS) at different time points. Through fitting the data with the metabolic kinetic model, the corresponding kinetic parameters were determined for plasma and tissues, including kidney, liver, heart, muscle, and gonad. While the metabolic kinetics of sodium selenite in plasma, liver, and kidney of rats was well reflected by a two-compartment open model, that in heart and gonad was fitted to a one-compartment open model, and that in muscle was fitted to a one-compartment open model with a lag time. The results indicate that sodium selenite was absorbed by plasma and tissues quickly and was eliminated slowly after intragastric administration. Based on the results, we propose that multi-supplementation of Se with low dosage is superior to single supplementation with high dosage, in terms of avoiding selenosis.


Asunto(s)
Gónadas/metabolismo , Corazón , Riñón/metabolismo , Hígado/metabolismo , Músculos/metabolismo , Selenito de Sodio/farmacocinética , Administración Oral , Animales , Femenino , Gónadas/química , Riñón/química , Cinética , Hígado/química , Masculino , Músculos/química , Ratas , Ratas Wistar , Selenito de Sodio/administración & dosificación , Selenito de Sodio/sangre , Distribución Tisular
2.
J Neurol Sci ; 323(1-2): 52-5, 2012 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-22938733

RESUMEN

Recent genome-wide association studies (GWAS) have identified two key SNPs (rs11833579 and rs12425791) on chromosome 12p13 that were significantly associated with stroke in Caucasians. However, the validity of the association has remained controversial. We performed genetic association analyses in a very unique population which has 60% European ancestry and 40% East Asian ancestry. No significant association between these two SNPs and ischemic stroke was detected in this Chinese Uyghur population.


Asunto(s)
Isquemia Encefálica/genética , Cromosomas Humanos Par 12/genética , Etnicidad/genética , Polimorfismo de Nucleótido Simple , Anciano , Alelos , Población Negra/genética , Glucemia/análisis , Isquemia Encefálica/etnología , Estudios de Casos y Controles , Cefalometría , China/epidemiología , Comorbilidad , Etnicidad/historia , Etnicidad/estadística & datos numéricos , Europa (Continente)/etnología , Asia Oriental/etnología , Femenino , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Estudio de Asociación del Genoma Completo , Haplotipos , Historia Antigua , Migración Humana/historia , Humanos , Lípidos/sangre , Lipoproteínas/sangre , Masculino , Persona de Mediana Edad , Factores de Riesgo , Población Blanca/genética
3.
Zhonghua Yu Fang Yi Xue Za Zhi ; 40(5): 328-31, 2006 Sep.
Artículo en Chino | MEDLINE | ID: mdl-17166423

RESUMEN

OBJECTIVE: To compare the effects of soy isoflavone with supplemental calcium to soy isoflavone or Ca alone on preservation of bone mineral density (BMD) and the expression of insulin-like growth factor (IGF)-I. METHODS: Sprague-Dawley (SD) female Rats, 6 months old, were ovariectomized and randomized into five groups: sham-operated group (n = 10) or ovx (n = 40) group. Shams were fed a 3.272 g/kg Ca diet. Ovx rats were randomized to a 3.272 g/kg Ca diet alone (OVX) or with soy isoflavone (SI) extract (37.95 mg/kg.bw) or to a supplemental Ca diet (Ca, 4.676 g/kg) alone or a supplemental Ca diet with the isoflavone extract (SI + Ca) for 12 weeks. BMD of femur was measured by scanner of bone mineral density. The level of IGF-1 mRNA expression was measured by reverse transcriptase-polymerase chain reaction (RT-PCR), respectively. RESULTS: There was no significant difference between group Sham (0.267 +/- 0.008) and group SI + Ca (0.263 +/- 0.007) g/cm(2) (P > 0.05) on femur BMD of distal end. Femur BMD of distal end in group Sham and group SI + Ca was greater (P < 0.05) as compared to group OVX (0.245 +/- 0.005) g/cm(2), SI (0.258 +/- 0.011) g/cm(2) or Ca (0.255 +/- 0.004) g/cm(2), P < 0.05. The liver tissue IGF-1 mRNA contents (IGF-1 cDNA/B-actin cDNA) were significantly decreased in group Sham (0.200 +/- 0.023) g/cm(2), SI (0.278 +/- 0.019) g/cm(2), Ca (0.302 +/- 0.026) g/cm(2) or SI + Ca (0.231 +/- 0.025) g/cm(2) as compared to group OVX (0.362 +/- 0.031) g/cm(2), P < 0.05; The liver tissue IGF-1 mRNA contents (IGF-1 cDNA/B-actin cDNA) were significantly decreased in group SI + Ca (0.231 +/- 0.025) g/cm(2) compared to group SI (0.278 +/- 0.019) g/cm(2) and Ca (0.302 +/- 0.026) g/cm(2), P < 0.05. CONCLUSIONS: Soy isoflavones combined with supplemental Ca are more protective against the loss of femur BMD than soy isoflavones or supplemental Ca diet alone. The dose of SI (37.95 mg/kg.bw) might significantly restrain the rising of the liver tissue IGF-1 mRNA contents caused by ovariectomy.


Asunto(s)
Densidad Ósea/efectos de los fármacos , Calcio de la Dieta/farmacología , Factor I del Crecimiento Similar a la Insulina/biosíntesis , Isoflavonas/farmacología , Hígado/efectos de los fármacos , Animales , Femenino , Factor I del Crecimiento Similar a la Insulina/genética , Hígado/metabolismo , Ovariectomía , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Glycine max
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA